Literature DB >> 1020054

Myocardial injury induced by a single dose of adriamycin: an electron microscopic study.

G Lambertenghi-Deliliers, P L Zanon, E F Pozzoli, O Bellini.   

Abstract

Adriamycin cardiomyopathy has been studied under the electron microscope using myocardial ventircular cells of CRF mice, previously treated with 10 mg/kg body weight of the drug given in a single intravenous injection. Within 10 min myocardial cell nucleoli show a nucleolonema fragmentation, and during the following 3 hours they acquire the nucleolar segregation pattern. Fourteen hours after drug injection, nucleolar morphology again becomes normal, while areas of focal degeneration, characterized by damaged mitochondria and enlarged smooth reticulum cisternae, appear in the sarcoplasm. One to 3 days later the degeneration process involves the myofibrillar component, and after 50 days the great majority of myocardial ventricular cells is damaged. The early appearance and the functional significance of nucleolar segregation support the hypothesis that adriamycin cardiotoxicity might be dependent on its ability to bind to myocardial cell DNA. The consequent failure of RNA and protein synthesis, impairing the continuous renewal of myofibrillar and mitochondrial components of the cell, might explain the progressive myocardial damage.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1020054     DOI: 10.1177/030089167606200506

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916


  11 in total

1.  Cytomorphological lesions induced by chemotherapeutic agents in transitional cell carcinoma in vitro.

Authors:  D J Weaver; B A Barrett; G Ross; E H Adelstein
Journal:  In Vitro Cell Dev Biol       Date:  1986-11

Review 2.  Adriamycin-induced heart failure: mechanism and modulation.

Authors:  P K Singal; T Li; D Kumar; I Danelisen; N Iliskovic
Journal:  Mol Cell Biochem       Date:  2000-04       Impact factor: 3.396

Review 3.  Cardiac side effects of anticancer treatments: new mechanistic insights.

Authors:  Carrie Geisberg; Laura Pentassuglia; Douglas B Sawyer
Journal:  Curr Heart Fail Rep       Date:  2012-09

4.  Accumulation and metabolism of new anthracycline derivatives in the heart after IV injection into mice.

Authors:  D Deprez-de Campeneere; R Baurain; A Trouet
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

5.  Similar changes in cardiac morphology and DNA synthesis induced by doxorubicin and 4'-epi-doxorubicin.

Authors:  K Wassermann; K Mølgaard; E Steiness
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

6.  Evaluation of free radical effects and catecholamine alterations in adriamycin cardiotoxicity.

Authors:  J A Jackson; J P Reeves; K H Muntz; D Kruk; R A Prough; J T Willerson; L M Buja
Journal:  Am J Pathol       Date:  1984-10       Impact factor: 4.307

7.  Cytotoxic effects of adriamycin on mouse hypoglossal neurons following retrograde axonal transport from the tongue.

Authors:  L Bigotte; Y Olsson
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

8.  Effects of 5-iminodaunorubicin on nucleoli of rats.

Authors:  J H Peters; M J Evans; R A Jensen; E M Acton
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

9.  Glutathione peroxidase 1-deficient mice are more susceptible to doxorubicin-induced cardiotoxicity.

Authors:  Jinping Gao; Ye Xiong; Ye-Shih Ho; Xuwan Liu; Chu Chang Chua; Xingshun Xu; Hong Wang; Ronald Hamdy; Balvin H L Chua
Journal:  Biochim Biophys Acta       Date:  2008-06-11

Review 10.  Doxorubicin (adriamycin) cardiomyopathy.

Authors:  E Saltiel; W McGuire
Journal:  West J Med       Date:  1983-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.